Nearly £5M has been awarded to two flagship research projects into antimicrobial resistance (AMR), in one of the largest UK public grant investments in this area, according to MRC and BBSRC. The grants will go to leading lights at the University of Warwick (£3.19M) and the University of Cambridge (£1.58M) and will involve multi-partner collaborations in order to tackle the growing threat of superbugs.
A ROCKET carrying technology developed with BBSRC support has blasted into space for use in experiments on board the International Space Station (ISS). Alvetex® Scaffold technology, produced by Durham University spin-out company Reinnervate, allows cells to be grown in three dimensions (3D), overcoming problems with two-dimensional (2D) culture methods and offering a more life-like model of how cells grow in tissues.
The most virulent strains of Streptococcus suis, the leading cause of bacterial meningitis in adult humans in parts of southeast Asia and in pigs around the world, are likely to have evolved and become widespread in pigs at the same time as changes in rearing practices, according to research from an international consortium published today in the journal Nature Communications.